Overview

VPD-737 for Treatment of Chronic Pruritus

Status:
Completed

Trial end date:
2015-04-15

Target enrollment:

Participant gender:

Summary

A study of a several doses of a novel treatment for chronic itch compared to placebo for patients whose condition has not responded to other treatments

Phase:

Phase 2

Details

Lead Sponsor:

Menlo Therapeutics Inc.
Vyne Therapeutics Inc.

Treatments:

Serlopitant